[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362180-105":59,"doc-detail-362180-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrating-single-cell-and-bulk-transcriptomes-identifies-b-cell-features-associated-with-neoadjuvant-chemoradiotherapy-sensitivity-in-rectal-cancer","Integrating single-cell and bulk transcriptomes identifies B cell features associated with neoadjuvant chemoradiotherapy sensitivity in rectal cancer","","Neoadjuvant chemoradiotherapy (nCRT) is the standard for locally advanced rectal cancer, yet patient responses vary widely. This study characterizes B-cell types linked to nCRT response or resistance by integrating single-cell RNA-seq with bulk transcriptome data using the “Scissor” algorithm. A defined B-cell subpopulation marked by HLA-DRB5, HLA-DQA2, HLA-DQB1, CD74, and ACTG1 associates with response, enabling three patient subtypes and a machine-learning pCR predictor with strong validation performance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrating-single-cell-and-bulk-transcriptomes-identifies-b-cell-features-associated-with-neoadjuvant-chemoradiotherapy-sensitivity-in-rectal-cancer/362180/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrating-single-cell-and-bulk-transcriptomes-identifies-b-cell-features-associated-with-neoadjuvant-chemoradiotherapy-sensitivity-in-rectal-cancer/362180.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of the study?","Question",{"text":112,"@type":113},"To identify B-cell types associated with response or resistance to neoadjuvant chemoradiotherapy in rectal cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were single-cell and bulk transcriptome data used?",{"text":117,"@type":113},"The study applied the “Scissor” algorithm to integrate single-cell RNA-seq data with bulk transcriptome data, linking B-cell subpopulations to nCRT response.",{"name":119,"@type":110,"acceptedAnswer":120},"Which B-cell signature is associated with nCRT response?",{"text":121,"@type":113},"A B-cell subpopulation co-expressing HLA-DRB5, HLA-DQA2, HLA-DQB1, CD74, and ACTG1 is significantly associated with nCRT response.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},362180,1790701816,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIntegrating single-cell and bulk transcriptomes identifies B cell features associated with neoadjuvant chemoradiotherapy sensitivity in rectal cancer  \nHuang Xia3,7,8, Yu Lin1,4,5,8, Zeyuan Li1,4,5, Lijing Zeng6, Qiwei Yao2,7􀀍, Benhua Xu1,4,5􀀍 & Rong Zheng1,4,5􀀍  \nNeoadjuvant chemoradiotherapy (nCRT) is the main treatment for Locally Advanced Rectal Cancer (LARC). The response to nCRT varies from a complete response to no response. The impact of the B cells in this process is poorly understood. This study aimed to characterize the B cells types associated with response or resistance to nCRT. We applied the “Scissor” algorithm to integrate single-cell RNA-seq data with bulk transcriptome data from colorectal cancer samples, thereby identifying B cell subpopulations associated with nCRT response and exploring the clinical significance of B cellrelated characteristic genes in nCRT for rectal cancer. At the single-cell level, we identified a B cell subpopulation characterized by the expression of HLA-DRB5, HLA-DQA2, HLA-DQB1, CD74, and ACTG1, which was associated with nCRT response in rectal cancer. Using subpopulation-specific trait genes, rectal cancer patients were classified into three distinct subtypes with unique features. Subtype A shows higher PD-L1 expression suggesting that patients in this subgroup are more likely to achieve favorable responses to immunotherapy. Subtype C shows lower hypoxia scores and a higher proportion of patients deriving clinical benefit from nCRT, suggesting that this subgroup may be more sensitive to neoadjuvant treatment. We developed a machine learning-based predictive model for pathological complete response (pCR) to nCRT in rectal cancer, achieving an area under the curve (AUC) of 0.911 in the training set and 0.819 in the 64-sample validation cohort. This study reveals that a B cell subpopulation characterized by the co-expression of HLA-DRB5, HLA-DQA2, HLA-DQB1, CD74, and ACTG1 is significantly associated with nCRT response in rectal cancer. These findings offer actionable insights for optimizing clinical treatment strategies, including patient stratification and personalized therapy selection.  \nKeywords Rectal cancer, Radiotherapy, Radiosensitivity, Radioresistance  \nRectal cancer ranks among the four most prevalent cancers with the highest mortality rates globally, accounting for 3.2% of all cancer-related deaths1.For patients with Locally Advanced Rectal Cancer (LARC), Neoadjuvant chemoradiotherapy (nCRT) followed by radical surgery—specifically total mesorectal excision —has been established as the standard treatment modality according to the National Comprehensive Cancer Network (NCCN) clinical practice guidelines2. This treatment strategy has demonstrated efficacy in reducing local recurrence, with 8%–20% of complete responders achieving organ preservation3–5. However, not all LARC  \n1Department of Radiation Oncology, Fujian Medical University Union Hospital, Fuzhou, China. 2Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350000, Fujian, P. R. China. 3I Clinical Trial Ward, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350000, Fujian Province, China. 4Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors, Fujian Medical University), Fuzhou, Fujian Province, People’s Republic of China. 5Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies), Fuzhou, Fujian Province, People’s Republic of China. 6Fujian Medical University, Fuzhou, China. 7NHC Key Laboratory of Cancer Metabolism(Fujian Cancer Hospital), Fuzhou 350000, Fujian Province, China. 8Huang Xia and Yu Lin contributed equally to this work. 􀀍 [email: yqwviva@126.com](email: yqwviva@126.com); [benhuaxu@163.com](benhuaxu@163.com); [zhengrrong@outl","cbCaiiRSSQwKAbbL","https://ap.wps.com/l/cbCaiiRSSQwKAbbL","pdf",3641278,11,"English","# Abstract\n# Introduction\n## Clinical context of nCRT in locally advanced rectal cancer\n## Need for biomarkers\n## Role of the tumor immune microenvironment and B cells","[{\"question\":\"What was the main goal of the study?\",\"answer\":\"To identify B-cell types associated with response or resistance to neoadjuvant chemoradiotherapy in rectal cancer.\"},{\"question\":\"How were single-cell and bulk transcriptome data used?\",\"answer\":\"The study applied the “Scissor” algorithm to integrate single-cell RNA-seq data with bulk transcriptome data, linking B-cell subpopulations to nCRT response.\"},{\"question\":\"Which B-cell signature is associated with nCRT response?\",\"answer\":\"A B-cell subpopulation co-expressing HLA-DRB5, HLA-DQA2, HLA-DQB1, CD74, and ACTG1 is significantly associated with nCRT response.\"}]","Integrating single-cell and bulk transcriptomes identifies B cell features associated with neoadjuvant chemoradiotherapy sensitivity in rectal cancer | PDF",1790146696,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f69828df3d8a0cb8dd491470105bc69c.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77e9234fe6dfb256daedb9b165120224.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2318c82199ebec2b6d0ff1fb0add020b.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27290e5667f580c7154d8189576f6aa1.webp",980,1287]